|
An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy |
|
Live |
06/27/2024 - 5:30pm EDT |
$0.00 |
|
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum |
|
Live |
05/30/2024 - 8:00am EDT |
$0.00 |
|
Following a Moving Target: Current and Emerging Strategies for the Prevention and Management of COVID-19 in Patients with Multiple Sclerosis |
|
Live |
04/30/2024 - 12:00pm EDT |
$0.00 |
|
When the Default is Not Enough: An Emergency Medicine Clinician's Guide to Novel Amyloid-Related Imaging Abnormalities in Alzheimer's... |
|
Live |
03/25/2024 - 3:00pm EDT |
$0.00 |
|
Different Strokes: Addressing Real Clinician Questions and Controversies Surrounding Acute Management of Ischemic Stroke (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |
|
From Critique to Consensus: Quantifying & Clarifying Expert Perspectives on the Future Management of Alzheimer's Disease (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Neurology Module |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |
|
Module 2: Initiation and Selection of Disease Modifying Therapy |
|
Enduring |
|
$0.00 |
|
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Introductory Module |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |
|
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... |
|
Enduring |
|
$0.00 |
|
On Target with “OFF” Therapies: An Exploration of New Agents and Strategies for Parkinson’s Disease (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
|
Calibrating COVID-19: The Interplay of Disease Modifying Therapy and Vaccination in Patients with Multiple Sclerosis (Credit Expired) |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward